ISRCTN67541323已完成未知
Cardiovascular events and mortality in systemic sclerosis (SSc): a study of the effect of iloprost on these and on disease progression
niversity of Dundee (UK)0 个研究点目标入组 215 人开始时间: 2005年9月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 215
研究概览
简要总结
- 2016 results in https://doi.org/10.1177%2F0165025416652248 (added 17/01/2019) 2. 2017 results of promoting child development through group-based parent support within a cash transfer program in https://www.ncbi.nlm.nih.gov/pubmed/27748620 (added 17/01/2019) 3. 2017 results of a parenting program among women who began childbearing as adolescents and young adults in https://www.ncbi.nlm.nih.gov/pubmed/28838751 (added 17/01/2019) 4. 2017 results of stimulating parenting practices in indigenous and non-indigenous Mexican communities in https://www.ncbi.nlm.nih.gov/pubmed/29295595 (added 17/01/2019) 5. 2018 results in https://doi.org/10.1016/j.ecresq.2018.08.009 (added 17/01/2019) 6. 2017 results in Spanish in https://www.siicsalud.com/dato/experto.php/149503 (added 30/04/2020)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Subjects will be patients with both limited and diffuse SSc, as our pilot work has shown atherosclerotic vascular disease to occur in both groups. The patients considered for this study will be as follows:
- •1. Any patient fulfilling Arthritis Research Campaign (ARC) criteria for SSc
- •2. Any patient with Raynaud?s Phenomenon and at least 3 other features of limited SSc
- •3. Any patient with Raynaud?s Phenomenon and the presence of an SSc-related autoantibody (e.g. anticentromere, antitopo1 [scleroderma 70], anti-U1RNP, anti-ThRNP, anti-U3RNP, anti-PmScl)
- •All will be >40 years of age. These patients will be recruited from Connective Tissue Disease clinics throughout Tayside, Fife, Strathclyde, Lothian, Grampian, Yorkshire, Bath, Northamptonshire and Ireland. Patients with SSc will be invited to attend the clinics to have their vascular risk factors assessed. Volunteers will then be asked to give informed consent and if that consent is given, enter the screening phase of the study
排除标准
- •1. Suspected serious physical illness such as cancer which may be expected to curtail life expectancy
- •2. Psychiatric illness (reported by GP)
- •3. Congenital heart disease
- •4. Any patient who is pregnant or who wishes to become pregnant within the time course of the study
研究者
相似试验
进行中（未招募）
1 期
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849EUCTR2012-003946-34-CZVIVUS, Inc.16,000
进行中（未招募）
1 期
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 14.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849EUCTR2012-003946-34-SKVIVUS, Inc.16,000
进行中（未招募）
不适用
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.0Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849EUCTR2012-003946-34-GBVIVUS, Inc.16,000
已完成
不适用
Mortality and risk factors for cardiovascular and non-cardiovascular disease in Japanese with impaired glucose metabolismJPRN-UMIN000036648Hiroshima Atomic Bomb Casualty Council19,248
已完成
不适用
Risk factors for mortality and cardiovascular diseases in older adults in a primaray care setting – longitudinal analysis of the getABI-studyRisk factors for mortality and cardiovascular diseasesI70.20DRKS00011624Ruhr-Universität Bochum6,880